Dragon's Blood Sap

Dragon's Blood Sap is a natural resinous exudate harvested from the Croton lechleri tree, native to the Amazon basin of Peru. This listing offers 1000 liters of raw sap, collected and processed under basic hygiene conditions. The product is supplied in two packaging formats: 800-liter industrial drums and 20-liter gallon containers. No chemical additives or preservatives are added during collection or storage. The sap is unrefined and retains its natural viscosity and deep red coloration, consistent with traditional harvesting methods in the Peruvian Amazon.

The sap contains high concentrations of taspine and other proanthocyanidins, compounds known in pharmacological literature for their wound-healing and anti-inflammatory properties. Typical purity levels in unprocessed sap range from 85% to 92% solids by weight, with moisture content averaging 8% to 12%. These values align with standard industry benchmarks for raw, unrefined Dragon's Blood Sap from Peru. No certifications for pharmaceutical grade are claimed or confirmed by the supplier, though the product is handled in a manner consistent with food-grade hygiene protocols.

This sap is primarily sourced by herbal extract manufacturers, natural product formulators, and traditional medicine producers seeking unadulterated raw material. Buyers typically use it as a base for topical ointments, wound dressings, or dietary supplements. Trade terms require 50% advance payment and 50% against documents at sight. Packaging is standardized to 800L drums or 20L containers, with no custom sizes available. The product is shipped dry and non-hazardous under UN3373 for biological substances.

Quinua Andina operates from Lima, Peru, with a physical address listed as Av. Guardia Peruana, Chorrillos. The company is registered as a supplier of natural botanical extracts and has no public website or third-party verification beyond its basic platform profile. It holds a harbor trust tier, indicating minimal transaction history and no documented export certifications. The listing confirms no response rate or average response time, suggesting limited buyer communication capability.

The company does not claim any processing facilities, laboratory testing, or export experience beyond the direct sale of this inventory. There is no mention of cultivation, harvesting partnerships, or supply chain traceability. Buyers should treat this as a one-time stock offering rather than an ongoing supplier relationship. No references to past clients, production volume, or regulatory compliance are provided.